Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ulodesine (BCX4208) is a purine nucleoside phosphorylase (PNP) inhibitor that inhibits PNP with an IC50 value of 2.293 nM/L. Ulodesine may be used to study hyperuricaemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 139.00 | |
5 mg | In stock | $ 347.00 | |
10 mg | In stock | $ 563.00 | |
25 mg | In stock | $ 890.00 | |
50 mg | In stock | $ 1,230.00 | |
100 mg | In stock | $ 1,670.00 | |
500 mg | In stock | $ 3,350.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 317.00 |
Description | Ulodesine (BCX4208) is a purine nucleoside phosphorylase (PNP) inhibitor that inhibits PNP with an IC50 value of 2.293 nM/L. Ulodesine may be used to study hyperuricaemia. |
Targets&IC50 | PNP:2.293 nM |
In vivo | Ulodesine intravenously effectively eradicates uric acid accumulations in the bloodstream of the mouse model.[1] |
Synonyms | BCX4208 |
Molecular Weight | 264.28 |
Formula | C12H16N4O3 |
CAS No. | 548486-59-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (85.1 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ulodesine 548486-59-5 Metabolism Endogenous Metabolite BCX 4208 BCX4208 BCX-4208 inhibitor inhibit